Blanket Purchase Agreement V797P5224B-VA797P15A0005

This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Bausch Health US LLC, a global pharmaceutical and medical device company, to provide the VA with the specialized medical isotopes ammonium chloride and calcium disodium versenate. The $530,000 single award BPA, established under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB), has an ultimate completion date of October 16, 2025. It is designed to streamline the...

This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Nephron Sterile Compounding Center LLC on March 1, 2020, with a potential value of $2.5 million. The BPA is for specialized compounded intravenous solutions with no set-aside used. The period of performance extends through the last date to order of September 30, 2023. The BPA facilitates recurring orders for specific pharmaceutical products and supplies, including Phenylephrine HCI Injection,...

The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 9, has awarded a single-award Blanket Purchase Agreement (BPA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The BPA has a ceiling value of $49,212,356.34 and a period of performance from December 2024 to November 2029, with five ordering periods. The BPA is for the manufacture and delivery of Pluvicto (lutetium Lu 177...

This Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to Servier Pharmaceuticals LLC as a single-award contract with potential value of $12 million. The BPA is for the purchase of the pharmaceutical products Asparlas and Oncaspar, to be delivered over a base year and four option years. The Department of Veterans Affairs provides healthcare services to military veterans. This BPA aims to procure chemotherapy drugs Asparlas and Oncaspar...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a blanket purchase agreement to Advanced Accelerator Applications USA Inc. to deliver doses of the pharmaceutical PLUVICTO. The BPA has a potential value of $7,790,954.40 and a period of performance through December 2024. Two task orders have been issued against this BPA. The first task order, awarded in January 2024, is valued at $1,688,040.12 to provide PLUVICTO doses through...

The Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 15 has awarded a Blanket Purchase Agreement (BPA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The BPA, valued at $1,493,220.26, is for the delivery of the radiopharmaceutical product PLUVICTO (Lutetium Lu 177 Vipivotide Tetraxetan) over the contract period ending July 31, 2025. Advanced...

This federal contract IDV award is a Blanket Purchase Agreement (BPA) issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The contract has a ceiling value of $6,000,000 and a period of performance from January 1, 2025 through December 31, 2025. The primary product being procured under this BPA is the radiopharmaceutical...

The Department of Veterans Affairs VISN 22 has awarded an Indefinite Delivery Contract (IDC) to Central Admixture Pharmacy Services Inc., doing business as Caps, for the provision of Total Parenteral Nutrition (TPN) supplies and services. This single-award, firm-fixed-price contract has a ceiling value of $4,000,000 and a period of performance from September 16, 2024 to September 15, 2029. The contractor shall provide compounded sterile preparation of TPN products, including Plenamine 15%,...

This Blanket Purchase Agreement (BPA) contract was awarded by the Department of Veterans Affairs (VA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract has a total ceiling value of $6,900,000 and a period of performance through September 30, 2025. The primary purpose of this contract is to procure the radiopharmaceutical product PLUVICTO, which is used in cancer treatment and diagnostic...

This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The single-award, $1,099,043 contract provides for the supply of Verapamil IR tablets to the VA, Bureau of Prisons (BOP), and Indian Health Service (IHS) over a base year from June 1, 2020 to May 31, 2021, with four one-year option periods. The contract was competed as an unrestricted...